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The neuroendocrine system governs essential survival and homeostatic functions. For
example, growth is needed for development, thermoregulation maintains optimal core
temperature in a changing environment, and reproduction ensures species survival.
Stress and immune responses enable an organism to overcome external and internal
threats while the circadian system regulates arousal and sleep such that vegetative and
active functions do not overlap. All of these functions require a significant portion of
the body’s energy. As the integrator of the neuroendocrine system, the hypothalamus
carefully assesses the energy status of the body in order to appropriately partition
resources to provide for each system without compromising the others. While doing
so the hypothalamus must ensure that adequate glucose levels are preserved for brain
function since glucose is the primary fuel of the brain. To this end, the hypothalamus
contains specialized glucose sensing neurons which are scattered throughout the nuclei
controlling distinct neuroendocrine functions. We hypothesize that these neurons play
a key role in enabling the hypothalamus to partition energy to meet these peripheral
survival needs without endangering the brain’s glucose supply. This review will first
describe the varied mechanisms underlying glucose sensing in neurons within discrete
hypothalamic nuclei. We will then evaluate the way in which peripheral energy status
regulates glucose sensitivity. For example, during energy deficit such as fasting specific
hypothalamic glucose sensing neurons become sensitized to decreased glucose. This
increases the gain of the information relay when glucose availability is a greater concern
for the brain. Finally, changes in glucose sensitivity under pathological conditions (e.g.,
recurrent insulin-hypoglycemia, diabetes) will be addressed. The overall goal of this
review is to place glucose sensing neurons within the context of hypothalamic control
of neuroendocrine function.
Keywords: glucose-excited neurons, glucose-inhibited neurons, hypoglycemia, starvation, glucose homeostasis,
orexin, agouti-related peptide, nitric oxide
INTRODUCTION
Our neuroendocrine systems maintain homeostasis against
changing internal and external stressors. In order to do this,
it is necessary to carefully partition fuel to each system which
requires energy without compromising a constant brain glucose
supply. The primary responsibility for this fuel partitioning falls
upon the hypothalamus. The hypothalamus integrates autonomic
responses and endocrine function with behaviors, especially those
concerned with the homeostatic requirements of everyday life.
There are five basic physiological needs which are governed by
the hypothalamus. These are the regulation of blood pressure and
electrolyte composition, body temperature, energy metabolism,
reproduction, and the emergency response to stress. In order
to do this, the hypothalamus receives sensory information from
the entire body. This input includes visceral sensory afferents as
well as circulating hormones. The hypothalamus possesses inter-
nal sensory neurons which detect changes in local temperature,
osmolality, electrolytes and nutrients such as glucose and free
fatty acids. The hypothalamus then compares the information
from this input with biological set points and adjusts an array of
autonomic, endocrine and behavioral responses in order to main-
tain homeostasis (Oomura et al., 1969; Steffens et al., 1972, 1988;
Sawchenko, 1998; Beverly et al., 2001; Lindberg et al., 2013; Valassi
et al., 2014). This review will focus on the mechanisms underly-
ing hypothalamic glucose sensing and the role of this system in
glucose homeostasis.
Glucose is the primary fuel of the brain, thus it is essen-
tial to maintain adequate levels for brain function at all times.
Hypothalamic glucose sensing neurons were discovered in the
1960s, and there is evidence that they play a role in maintain-
ing cerebral glucose levels (Anand et al., 1964; Oomura et al.,
1964; Levin et al., 2004; Fioramonti et al., 2010b). The hypotha-
lamus also receives and integrates input from other central and
peripheral glucose sensors (Routh et al., 2013). Interestingly, glu-
cose sensing neurons make up subpopulations of hypothalamic
nuclei involved in varied aspects of neuroendocrine function
(Fioramonti et al., 2007; Gonzalez et al., 2008; Melnick et al.,
2011; Roland and Moenter, 2011; Stanley et al., 2013). This sug-
gests that glucose sensing neurons may contribute to the coordi-
nation of nutrient partitioning amongst neuroendocrine systems.
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However, given the need of the brain for glucose, we hypothesize
that the main function of hypothalamic glucose sensing neurons
is to ensure that brain needs are prioritized above those of other
neuroendocrine or bodily functions.
GLUCOSE ENTRY INTO THE BRAIN
When considering the physiological significance of brain glu-
cose sensing, it is important to consider the regulation of glucose
entry into the brain. The saturable glucose transporter isoform-
1 is the primary glucose transporter at the blood brain barrier
(Cardoso et al., 2010). However, the regulation of blood glu-
cose entry is clearly more complicated than simple transport,
and suggests the evidence of distinct diffusion barriers as will be
discussed below (Mullier et al., 2009; Langlet et al., 2013). As a
result, glucose concentrations in the brain are lower than that of
the periphery. A landmark study by Silver and Erecinska in the
1990s showed that ventromedial hypothalamic (VMH) glucose
levels in anesthetized rats were ∼2.5mM at baseline (∼7.6mM
blood glucose due to the hyperglycemic effects of anesthesia)
and 0.16mM during hypoglycemia (∼2.8mM blood glucose).
In this study, VMH glucose levels never exceeded 4.5mM even
when blood glucose was raised to 20mM (Silver and Erecinska,
1994). Later microdialysis studies using the zero net flux tech-
nique in awake animals indicated that brain glucose levels at
peripheral euglycemia (∼5.5mM) were ∼1.5–2mM, not only
in the hypothalamus but the hippocampus and striatum as well
(McNay and Gold, 1999; McNay et al., 2000, 2001; De Vries
et al., 2003). Brain glucose varies with blood glucose, declining
to ∼0.7mM after an overnight fast. During peripheral hypo-
glycemia, hypothalamic glucose fell to ∼0.3mM (Dunn-Meynell
et al., 2009). These studies indicate that hypothalamic glucose
levels range from ∼0.2 to 4.5mM as blood glucose levels vary
from pathological hypoglycemia to hyperglycemia. Physiological
hypothalamic glucose levels vary from ∼0.7 to 2.5mM between
the fasted and fed state. This issue is important because although
glucose concentration in the hypothalamus was first measured
nearly 20 years ago, until fairly recently the majority of in vitro
studies of glucose sensing neurons still used standard extracellular
solutions containing 10–20mM glucose. These glucose concen-
trations would even be considered analogous to diabetes when
occurring in the blood. Thus, experimental conditions need to be
considered when evaluating the relevance of the results obtained
from studies of glucose sensing neurons.
There are several likely reasons for the resistance to studies of
neurons in vitro using physiologically relevant glucose concentra-
tions. One technical reason is that lower glucose concentrations
were thought to be damaging to neurons in vitro or to cause neu-
ronal silencing (Mobbs et al., 2001). This was reflected by the fact
that until recently it was impossible to purchase stock neuronal
culture media containing less than 20mM glucose (media is now
available without glucose to allow investigator control). However,
for over 15 years our laboratory and others have routinely stud-
ied hypothalamic neurons in brain slices or after dissociation
using ∼2mM glucose in the bathing medium with no evidence
of neuronal damage or silencing (Levin et al., 1993; Routh et al.,
1997; Song et al., 2001; Kang et al., 2004; Wang et al., 2004; Song
and Routh, 2005, 2006; Burdakov et al., 2006; Canabal et al.,
2007b; Fioramonti et al., 2007; Gonzalez et al., 2008; Cotero and
Routh, 2009; Cotero et al., 2009; Murphy et al., 2009a,b; Melnick
et al., 2011; Medeiros et al., 2012; Karnani et al., 2013; Vazirani
et al., 2013). In fact, we find that glucose concentrations of 5mM
and higher obscure glucose sensing in some subtypes of glucose
sensing neurons (Canabal et al., 2007a).
A more compelling argument for the use of higher glucose
concentrations relates to brain regions near circumventricular
organs. One important example is the arcuate nucleus (ARC)
within the VMH which surrounds the median eminence. VMH
glucose levels discussed above are often taken to reflect those
within the larger ventromedial nucleus (VMN), which lies dor-
sal to the ARC. In contrast, since the median eminence possesses
a fenestrated endothelium it was assumed that ARC glucose lev-
els would be more similar to that of the blood than to the
VMN. However, Dunn-Meynell et al., showed that ARC and
VMN glucose levels do not differ (Dunn-Meynell et al., 2009).
In this regard, the work of Vincent Prevot and colleagues also
deserves careful consideration (Mullier et al., 2009). This group
has convincingly demonstrated that differential organization and
expression of the tight junction proteins within the ependymal
cells which line the third ventricle and the median eminence leads
to distinct patterns of diffusion from blood and cerebrospinal
fluid. When blue Evans dye was injected into the blood, stain-
ing was restricted to the median eminence and did not diffuse
into the ARC. In contrast, when the dye was injected into the
third ventricle, staining was present in the ARC but not in the
adjacent VMN. These data suggest that distinct diffusion barriers
exist between the cerebrospinal fluid, circumventricular organs
(e.g., median eminence) and the brain (even between adjacent
brain regions). However, the physiological significance of diffu-
sion from cerebrospinal fluid to the ARC is unclear given that
the cerebrospinal fluid is thought predominantly to drain the
brain. An even more intriguing observation from these investiga-
tors is that these barriers are not constant under all physiological
conditions. For example, during fasting and glucoprivation the
structural components of these hypothalamic diffusion barriers
were altered such that ARC glucose levels significantly exceeded
those in the VMN, although they did not reach blood levels.
Furthermore, blood glucose levels appear to play a key role in
driving these structural changes in the blood- and cerebrospinal
fluid-brain barriers (Langlet et al., 2013). Together, these data
indicate that while brain glucose levels are clearly lower than those
of the blood, there exist privileged routes for glucose diffusion
to distinct brain regions (e.g., from cerebrospinal fluid to ARC
but not VMN) which are regulated by nutritional status. These
observations also underscore the putative role of central glucose
sensing in modulating glucose levels in order to meet the needs of
the brain.
CELLULAR MECHANISMS OF GLUCOSE SENSING
The existence of glucose sensing neurons was suggested by 2
independent groups in 1964, one using cats and the other dogs
(Anand et al., 1964; Oomura et al., 1964). In these studies, recip-
rocal changes in single unit activity were measured in the VMH
and lateral hypothalamus (regions formerly called the “satiety”
and “feeding” centers, respectively) during intravenous glucose
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or insulin injections. Glucose increased neuronal activity in the
VMH while the converse occurred in the lateral hypothala-
mus. Later work from Oomura’s laboratory demonstrated that
hypothalamic neurons were directly regulated by glucose in vitro.
This group coined the terms glucose responsive for neurons that
increased their activity with increased glucose and glucose sen-
sitive for those that decreased their activity as glucose increased
(Oomura et al., 1964). Today, these subtypes of glucose sensing
neurons are more commonly referred to respectively as glucose-
excited (GE) or glucose-inhibited (GI) neurons based on their
response to physiological changes in extracellular glucose (Song
et al., 2001; Kang et al., 2004; Wang et al., 2004; Burdakov et al.,
2005; Melnick et al., 2011). The following discussion of glucose
sensing mechanism will focus primarily on studies using phys-
iological glucose concentrations unless this information is not
available. These data are summarized in Table 1. We are defin-
ing physiological glucose concentration as being below 5mM in
order to account for variability in blood or cerebrospinal fluid to
brain glucose ratio under differing physiological conditions. Data
from studies which used tissue or cellular preparations which do
not discriminate between the ARC and VMNwill be referred to as
“VMH,” whereas studies in which neuronal location was verified
Table 1 | Putative role of glucose-inhibited and glucose-excited neurons in substrate partitioning during energy deficit.
Nuclei/Peptide
phenotype
Glucose
Sensing
phenotype
Mechanism of
glucose sensing
Putative effect on
brain fuel supply
during energy deficit
Mechanism by
which brain fuel
may be altered
Representative references
ARC NPY Inhibited nNOS independent Increase Increase food intake
Decrease energy
expenditure
Initiate ketogenesis
Murphy et al., 2009b; Joly-Amado
et al., 2012; Leshan et al., 2012;
Warne et al., 2013; Wang et al.,
2014
ARC GHRH Inhibited Unknown Increase Caloric mobilization Stanley et al., 2013
VMN nNOS Inhibited NO/AMPK/Cl−channel Increase Glucagon,
epinephrine secretion
Song et al., 2001; Song and Routh,
2006; Murphy et al., 2009a;
Fioramonti et al., 2010a, 2013
LH orexin Inhibited Metabolism
independent
K+ channel
Increase Reward feeding
Arousal
Antunes et al., 2001; Burdakov
et al., 2005; Harris et al., 2005;
Gonzalez et al., 2008; Williams
et al., 2008; Sheng et al., 2014
LH NPY Inhibited K+ channel ? Marston et al., 2011
LH GABA Inhibited Metabolism
independent
Mixed ionic
conductance
? ? Karnani et al., 2013
PVN pre-
autonomic
Inhibited Unknown ? ? Melnick et al., 2011
LH MCH Excited K+ channel Decrease Anabolic (increase fat
mass)*
Burdakov et al., 2005; Naufahu
et al., 2013
PO/AHA
GnRH
Excited AMPK
Non–selective cation
channel
Decrease Divert fuels to
reproductive axis
Roland and Moenter, 2011; Beall
et al., 2012
VMN
unknown
Excited KATP channel ? ? Ashford et al., 1990a; Song et al.,
2001
PVN pre-
autonomic
Excited KATP independent
Non–selective cation
channel
? ? Melnick et al., 2011
The overall hypothesis presented here is that during energy deficit the glucose-sensing function of these neurons reinforces the mechanisms which provide brain-
specific fuels while reducing the drive for other fuel consuming neuroendocrine systems. The predictions regarding the putative effect on brain fuel supply and
underlying mechanisms are based on net positive input to downstream circuitry and would be reversed if their net effect was inhibitory.
*While MCH neurons increase food intake, they are associated with anabolic processes which could divert fuel away from the brain.
Frontiers in Systems Neuroscience www.frontiersin.org December 2014 | Volume 8 | Article 236 | 3
Routh et al. Hypothalamic glucose sensing
visually or via microdissection as being from one region or the
other will be referred to as such.
GLUCOSE-EXCITED (GE) NEURONS
GE neurons are found in many hypothalamic regions including
the ARC, VMN, anterior hypothalamus, paraventricular nucleus,
and the lateral hypothalamus (Oomura et al., 1964; Ashford et al.,
1990a,b; Shian and Lin, 1991; Burdakov et al., 2005; Melnick
et al., 2011; Roland and Moenter, 2011). The neurotransmit-
ter phenotype of VMN GE neurons is largely unknown and
there are conflicting reports regarding whether ARC POMC neu-
rons are GE neurons (Wang et al., 2004; Claret et al., 2007;
Fioramonti et al., 2007; Parton et al., 2007). In contrast, GE
neurons have been found among the gonadotropin releasing hor-
mone neurons (GnRH) of the anterior hypothalamus (Roland
and Moenter, 2011; Beall et al., 2012), the preautonomic neu-
rons in the paraventricular nucleus (Melnick et al., 2011), and the
melanin concentrating hormone neurons of the lateral hypothala-
mus (Burdakov et al., 2005). The mechanism underlying glucose
sensing by VMH GE neurons has been the most extensively char-
acterized. Michael Ashford was the first to show that the majority
of these GE neurons utilize a glucose sensing mechanism similar
to that of the pancreatic β- cell (Ashford et al., 1990a). That is, like
the β-cell, increased glucosemetabolism raises the ATP/ADP ratio
and closes the ATP sensitive potassium channel (KATP) leading
to depolarization. Despite the fact that Ashford’s original studies
were performed using non-physiological glucose concentrations,
his findings have stood the test of time (and glucose concentra-
tion) (Song et al., 2001). Barry Levin’s laboratory demonstrated
a second important similarity between many VMH GE neurons
and the pancreatic β-cell: the initial phosphorylation of glucose to
glucose-6-phosphate is catalyzed by the pancreatic form of hex-
okinase IV, glucokinase (Dunn-Meynell et al., 2002; Kang et al.,
2006). In addition to a lower affinity for glucose than other hex-
okinases, glucokinase is not subject to end-product inhibition.
This allows for activity at a rate proportional to glucose con-
centration (Magnuson, 1990). Thus, the presence of glucokinase
is often used to predict glucose sensing in neuronal popula-
tions (Navarro et al., 1996; Yang et al., 1999; Lynch et al., 2000;
Maekawa et al., 2000; Mobbs et al., 2001; Dunn-Meynell et al.,
2002; Levin, 2002; Penicaud et al., 2002; Ramonet et al., 2004;
Balfour et al., 2006; Kang et al., 2006; Zhou et al., 2010; Beall et al.,
2012).
In addition to the ubiquitous glucose transporter 3 (GLUT3),
subpopulations of VMH GE neurons also express GLUT2 and
the insulin-sensitive GLUT4. Interestingly, a fairly large percent-
age of GE neurons express both GLUT4 and the insulin receptor
(Kang et al., 2004). About 25% of VMH GE neurons possess the
sodium glucose co-transporter (SGLT) which could couple glu-
cose uptake with membrane depolarization (Kang et al., 2004).
The cellular fuel sensor AMP activated protein kinase (AMPK)
may mediate glucose sensing in some GE neurons. For example
AMPK dependent glucose sensing has been reported for POMC
neurons, as well as for the GnRHneurons in the anterior hypotha-
lamus (Claret et al., 2007; Roland and Moenter, 2011; Beall et al.,
2012). Finally, the KATP channel does not mediate glucose sens-
ing in all GE neurons. GnRH neurons and PVN GE neurons use
a non-selective cation channel, while the melanin-concentrating
hormone neurons use an unidentified K channel (Burdakov et al.,
2005; Melnick et al., 2011; Roland and Moenter, 2011). Thus,
while many GE neurons could be considered the brain’s “pancre-
atic β-cell,” there is clearly a high degree of heterogeneity within
this category of glucose sensing neurons.
GLUCOSE-INHIBITED (GI) NEURONS
GI neurons are also widely dispersed throughout the hypothala-
mus, including the VMN, ARC, paraventricular nucleus, dorso-
medial nucleus, and the lateral hypothalamus (Song et al., 2001;
Burdakov et al., 2005; Song and Routh, 2006; Fioramonti et al.,
2007; Williams et al., 2008; Marston et al., 2011; Melnick et al.,
2011). There are two broad categories of GI neurons, those whose
activity is regulated by glucose metabolism (e.g., by changes in
ATP) and those that respond to the glucose molecule itself. The
metabolism dependent GI neurons most likely utilize GK since,
like GE neurons, the majority of GI neurons express GK (Dunn-
Meynell et al., 2002; Kang et al., 2006).Moreover, like GE neurons,
subpopulations ofmetabolism dependent GI neurons also express
GLUT2, GLUT4, SGLT2, and/or the insulin receptor (Kang et al.,
2004). The most studied of the metabolism dependent GI neu-
rons are located in the VMH. These GI neurons are activated in
low glucose via an interaction between AMPK and the gaseous
messenger nitric oxide (NO) which leads to chloride channel
closure, membrane depolarization, and increased action poten-
tial frequency (Song et al., 2001; Song and Routh, 2005; Murphy
et al., 2009a; Fioramonti et al., 2010a). VMH NO production by
the neuronal NO synthase (nNOS) and NO signaling through
its receptor, soluble guanylyl cyclase (sGC) are critical for both
glucose sensing by GI neurons and the in vivo counterregula-
tory response (CRR) to hypoglycemia suggesting a role for these
GI neurons in hypoglycemia detection (Murphy et al., 2009a;
Fioramonti et al., 2010a, 2013). There is also a very significant
overlap between VMH NO producing neurons and GI neurons
(Canabal et al., 2007b). Thus, while the peptide neurotransmitter
phenotype of these GI neurons remains unclear, it is reasonable
to refer to them as nNOS-GI neurons based on their gaseous
transmitter phenotype.
The above studies provided consistent results using either elec-
trophysiological recordings of VMN GI neurons in brain slices
or membrane potential dye imaging in freshly isolated VMH
neurons. The electrophysiological experiments were performed
on visually identified VMN neurons; whereas studies using iso-
lated VMH neurons did not allow discrimination between VMN
and ARC neurons. It is likely that mechanistic data concern-
ing AMPK-NO signaling obtained from imaging isolated VMH
neurons reflect VMN vs. ARC GI neurons for several reasons.
Technically, VMN neurons vastly outnumber ARC neurons in
this preparation and thus the significant majority of GI neu-
rons analyzed would be VMN- vs. ARC-GI neurons. Moreover,
the ARC neuropeptide Y (NPY)/agouti-related peptide (AgRP)
co-expressing neurons, half of which are GI neurons, do not
express nNOS nor do changes in intracellular AMPK appear
to affect their activity (Sternson et al., 2005; Fioramonti et al.,
2007; Leshan et al., 2012). Thus, together these data suggest dis-
tinct glucose sensing mechanisms for VMN nNOS-GI and ARC
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NPY/AgRP-GI neurons. The exact cellular mechanism under-
lying glucose sensing in the ARC NPY/AgRP-GI neurons is
not known. However, it could still be argued that regardless
of what the mechanism is ultimately determined to be, the
NPY/AgRP-GI neurons are metabolism-dependent since they
are clearly regulated by changes in AMPK activity in presynap-
tic terminals synapsing onto NPY/AgRP neurons (Yang et al.,
2011).
Denis Burdakov’s laboratory has extensively characterized the
metabolism-independent, orexin expressing GI neurons, which are
only found in the lateral, perifornical and dorsomedial hypotha-
lamus (Burdakov et al., 2005; Gonzalez et al., 2008; Williams
et al., 2008). Orexin neurons are equally inhibited by glucose
and by the non-metabolizable glucose analog, 2-deoxyglucose.
Thus, they respond to the glucose molecule itself rather than
downstream metabolites (Gonzalez et al., 2008; Sheng et al.,
2014). Glucose clearly activates a leak tandem-pore potassium
(K2P) channel in these neurons (Burdakov et al., 2006; González
et al., 2009). Moreover, Twik-related acid-sensitive potassium-
like (TASK) 1/3 channels, which belong to the K2P ion chan-
nel family, regulate high frequency firing in orexin neurons.
However, TASK 1/3 channels do not appear to be critical for
glucose sensing (González et al., 2009). Thus, at the present
time the precise ion channel which mediates glucose inhibition
in metabolism-independent GI neurons remains to be deter-
mined. Interestingly, there are two different glucose responses for
metabolism-independent GI neurons. A non-adapting response
is characterized by sustained glucose inhibition, while “adapting”
GI neurons are transiently inhibited when glucose concentration
rises but resume firing action potentials after several minutes
in high glucose (Williams et al., 2008). The adaptive response
appears to be due to a spontaneous decrease in inhibitory K+ cur-
rents (Williams et al., 2008). In addition to the orexin neurons,
GI neurons also exist within the NPY and gamma-aminobutyric
acid (GABA) neurons of the lateral hypothalamus (Marston
et al., 2011; Karnani et al., 2013). The GABA-GI neurons are
also metabolism independent. However, they are distinct from
the orexin-GI neurons in that the glucose sensitive conductance
appears to be carried by a mixture of ion channels (Marston et al.,
2011). It is not known whether the lateral hypothalamic NPY-
GI neurons are metabolism dependent or independent (Karnani
et al., 2013). The paraventricular nucleus GI neurons may also be
metabolism independent because they do not appear to express
GK (Stanley et al., 2013).
GLUCOSE SENSING GLIAL CELLS
Neurons are not the only glucose sensitive cells within the brain.
An increasing body of knowledge suggests that glucose sensing
by hypothalamic glial cells may play an important role in glucose
and energy homeostasis. For example, the data discussed above
indicates that the cells composing the blood brain barrier are
responsive to changes in glucose (Langlet et al., 2013). Specialized
ependymal cells known as tanycytes which line the third ventri-
cle express GK, GLUT2 and KATP channels, suggesting that they
are capable of sensing glucose (Garcia et al., 2003). In support of
this, glucose increases intracellular calcium levels within cultured
tanycytes (Orellana et al., 2012). Hypothalamic GK inhibition by
alloxan in vivo reduces food intake, impairs the hyperglycemic
response to a glucoprivic challenge and destroys tanycytes; all of
which reverse 2 weeks after alloxan injection. These data sug-
gest that hypothalamic tanycytes play a role in the physiological
response to hypoglycemia (Sanders et al., 2004). Astrocytes also
play a role in glucose sensing. Numerous studies suggest that
the glucose transporter 2 (GLUT2) plays a role in hypothala-
mic glucose sensing (Garcia et al., 2003; Guillod-Maximin et al.,
2004; Marty et al., 2005; Bady et al., 2006; Stolarczyk et al.,
2010). Interestingly, hypothalamic GLUT2 is primarily expressed
in astrocytes (Guillod-Maximin et al., 2004). Thus, it is clear
that hypothalamic glucose sensing is a complex system involv-
ing coordination between a wide variety of neuronal and glial
populations.
REGULATION OF GLUCOSE SENSING BY SIGNALS OF
PERIPHERAL ENERGY HOMEOSTASIS
HORMONAL SIGNALS OF ENERGY HOMEOSTASIS
Hypothalamic glucose sensing is modulated by the hormonal
milieu which reflects peripheral energy homeostasis. Insulin and
the adipose derived hormone leptin, both of which are con-
sidered “satiety” hormones, inhibit VMH GE neurons in the
presence of high extracellular glucose by opening the KATP chan-
nel (Spanswick et al., 1997, 2000). The effect of insulin persisted in
physiological glucose concentrations (Cotero and Routh, 2009);
however leptin had no effect on VMH GE neurons in 2.5mM
glucose (Wang et al., 2004). Insulin also prevents inhibition of
VMH GE neurons when glucose is lowered (Cotero and Routh,
2009; Cotero et al., 2009). Interestingly, hypothalamic insulin
infusion suppresses hepatic glucose production in vivo (Rojas
and Schwartz, 2014). A role for VMH GE neurons in altered
glucose homeostasis is also suggested by the observation that
VMH GE neurons from db/db mice and fa/fa Zucker rats with
peripheral insulin resistance are also insulin resistant (Spanswick
et al., 2000; Cotero et al., 2009). Interestingly, ghrelin, which
is released from the stomach during hunger, indirectly inhibits
ARC POMC (GE?) neurons (Cowley et al., 2003; Ibrahim et al.,
2003). Similar effects of ghrelin and leptin on GE neurons is
counterintuitive. However, it is well established that leptin acti-
vates POMC neurons (Cowley et al., 2001). Moreover, the effect
of ghrelin on glucose sensitivity of POMC neurons has not yet
been evaluated nor is there agreement as to whether POMC neu-
rons are truly GE neurons (Wang et al., 2004; Fioramonti et al.,
2007).
Metabolically relevant hormones also regulate both the activ-
ity and the glucose sensitivity of GI neurons. Leptin inhibits ARC
NPY/AgRP neurons (50% of which are GI neurons) as well as
lateral hypothalamic orexin-GI neurons (Shiraishi et al., 2000;
Yamanaka et al., 2003; Kohno et al., 2007; Louis et al., 2010; Baver
et al., 2014). Leptin also blunts the activation of both VMH-
and lateral hypothalamic orexin-GI neurons by decreased glucose
(Murphy et al., 2009b; Sheng et al., 2014). In contrast, activa-
tion of VMN GI neurons by decreased glucose is blunted in
the neuronal insulin-receptor knockout (NIRKO) mouse (Diggs-
Andrews et al., 2010) and insulin stimulates NO production
by VMH GI neurons in decreased glucose (Canabal et al.,
2007b). These observations are consistent with insulin-induced
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potentiation of the response to low glucose in these neurons. The
effect of insulin on lateral hypothalamus orexin-GI neurons is
not clear. These neurons are clearly activated by insulin-induced
hypoglycemia; however whether this is simply because they are GI
neurons or whether insulin is having an independent effect is not
known (Griffond et al., 1999; Moriguchi et al., 1999; Cai et al.,
2001; Zhao et al., 2005). As predicted given the inhibitory effect
of leptin, ghrelin activates both NPY-GI and orexin-GI neurons
(Kohno et al., 2003; Yamanaka et al., 2003). Ghrelin also increases
the activation of orexin-GI neurons in low glucose (Sheng et al.,
2014).
NUTRIENTS OTHER THAN GLUCOSE
Hypothalamic glucose sensing neurons also respond to other
nutrient-related signals in addition to glucose. Within the VMH,
there is overlap between GE and GI neurons and neurons whose
activity is altered by free fatty acids and ketones (Wang et al.,
2005; Le Foll et al., 2013, 2014). Neuronal fatty acid sensing is
consistent with data showing that central fatty acid infusionmod-
ulates glucose-induced insulin secretion and peripheral insulin
sensitivity (Cruciani-Guglielmacci et al., 2004; Migrenne et al.,
2006; Marsollier et al., 2009; Le Foll et al., 2013). In contrast
to glucose and fatty acids, direct evidence of amino acid sens-
ing neurons has been elusive. Administration of the branched
chain amino acid L-leucine, but not valine, into the third ventri-
cle decreases food intake; an effect which appears to be mediated
by the hypothalamic mammalian target of rapamycin (mTOR)
(Cota et al., 2006). The mTOR inhibitor rapamycin restores NO
production by VMH GI neurons during hyperglycemia suggest-
ing potential overlap in glucose and amino acid sensing path-
ways in these neurons (Canabal et al., 2007a). Moreover, Blouet
et al. demonstrated that direct application of leucine increased
the action potential frequency of POMC neurons (Blouet et al.,
2009). Taken together these data support the hypothesis that
hypothalamic glucose sensing neurons integrate multiple nutri-
ent signals; however this has yet to be definitely shown for amino
acids.
PHYSIOLOGICAL ROLE OF GLUCOSE SENSING NEURONS
While the existence of glucose sensing neurons has been known
for half a century (Anand et al., 1964; Oomura et al., 1964),
their exact physiological functions remain elusive. In the follow-
ing discussion, we have attempted to relate what is known about
the different subpopulations of glucose sensing neurons with the
function of the region or peptide phenotype in which they are
found. Table 1 summarizes these data. Our overall hypothesis is
that glucose sensitivity within multiple populations of neurons
involved in metabolic control enables the brain to broadly rein-
force the neurocircuitry which compensates for energy deficit
when glucose levels fall. This would be beneficial in order to
ensure an adequate neuronal fuel supply (glucose, ketones) at all
times.
HYPOGLYCEMIA DETECTION
When considering a physiological role for glucose sensing neu-
rons, hypoglycemia detection seems an obvious choice, especially
since the majority of glucose sensing neurons are most sensi-
tive to a decline in extracellular glucose levels below that which
would be seen during normal fed conditions (Song et al., 2001;
Wang et al., 2004; Song and Routh, 2005; Murphy et al., 2009b).
This hypothesis is also attractive when considering that glucose
is the primary fuel of the brain and that hypoglycemia clearly
has deleterious central effects (Languren et al., 2013). Insulin-
induced hypoglycemia increases cfos activation in a number of
hypothalamic nuclei, including the ARC, the paraventricular and
dorsomedial nuclei and the lateral hypothalamus (Niimi et al.,
1995; Diggs-Andrews et al., 2010; Fergani et al., 2014). Moreover,
hypoglycemia or central glucoprivation induces cfos expression in
several known hypothalamic glucose sensing populations includ-
ing the lateral hypothalamic orexin neurons as well as NPY
neurons in the ARC, dorsomedial nucleus and lateral hypotha-
lamus (Cai et al., 2001; Ferenczi et al., 2010; Marston et al., 2011).
Interestingly, although the VMN contains GI neurons and plays a
role in hypoglycemia detection, cfos activation was not detected in
this brain region following insulin-induced hypoglycemia or glu-
coprivation (Niimi et al., 1995; Borg et al., 1997; Diggs-Andrews
et al., 2010; Zhu et al., 2010; Szepietowska et al., 2011; Stanley
et al., 2013). One reason for this apparent discrepancy may be
because activation of VMN nNOS-GI neurons by decreased glu-
cose requires the NO-sGC pathway, whichmay not be represented
by cfos activation.
Although VMN cfos does not increase after hypoglycemia,
functional studies support a key role for VMN GI neurons in
the CRR. For example, repetitive hypoglycemic episodes shift
the glycemic threshold for initiation of the CRR to lower glu-
cose levels (Dagogo-Jack et al., 1993; Cryer, 2013; Moheet et al.,
2014). Similarly, after recurrent hypoglycemia VMN GE and
GI neurons show blunted inhibition or activation, respectively,
as glucose levels decline (Song and Routh, 2006; Kang et al.,
2008; Fioramonti et al., 2010b). Moreover, VMH lactate infu-
sion in vivo blunts the CRR while lactate perfusion in vitro blunts
activation of VMN GI neurons by decreased glucose (Song and
Routh, 2005). VMH NO signaling is critical for glucose sens-
ing by VMN nNOS-GI neurons as well as for the full CRR.
That is, nNOS inhibition prevents activation of VMN nNOS-GI
neurons by decreased glucose and neurons which are activated
by decreased glucose are not detectable in brain sections from
nNOS knockout mice (Fioramonti et al., 2010a). Similarly, the
CRR is significantly impaired in nNOS knockout mice, after
VMH NOS or sGC inhibition, or when NO-sGC signaling is dis-
rupted by a post-translational modification of sGC known as
S-nitrosation which renders it NO resistant (Fioramonti et al.,
2010a, 2013). Interestingly, when S-nitrosation during recur-
rent hypoglycemia is prevented both glucose sensing by VMH
GI neurons as well as the CRR are preserved. Taken together,
these data suggest a clear role for GI, and in particular VMN
nNOS-GI, neurons in detecting hypoglycemia and initiating
the CRR.
FASTING AND STARVATION
In addition to hypoglycemia detection, another potential role for
glucose sensing neurons is to maintain the brain’s energy sup-
ply during starvation. In fact, since insulin-induced hypoglycemia
is an iatrogenic consequence of treating Type 1 and advanced
Type 2 Diabetes Mellitus in the modern world, glucose sensing
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neurons probably evolved as a defense against starvation. During
starvation, the hypothalamic-pituitary-adrenal axis and the sym-
pathetic nervous system play a key role in energy mobilization
(Straub et al., 2010). The energetic needs of the body and the
brain are first supplied by mobilization of liver glycogen stores
for gluconeogenesis. After several hours adipocyte lipolysis pro-
vides fatty acids, which then fuel most organ systems. However,
the brain cannot utilize fatty acids as fuel. Thus, preserving ade-
quate blood glucose for the brain during starvation is one of
the most important actions of the neuroendocrine system. When
liver glycogen is depleted, muscle catabolism is initially neces-
sary to provide amino acids as substrates for gluconeogenesis.
Muscle catabolism is clearly detrimental in the long term and
after several days of starvation, increased conversion of fatty acids
to ketones in the liver provides fuel to the brain and spares
lean body mass (Straub et al., 2010). It seems likely that glu-
cose sensing neurons, particularly GI neurons, are important for
informing the brain of the potential magnitude of a threat to
the brain energy supply during starvation and aiding in energy
mobilization.
In support of this, in general the hormonal changes which
occur during fasting (e.g., reduced leptin and increased ghrelin)
activate GI neurons and/or enhance their activation by decreased
glucose (Cai et al., 1999; López et al., 2000; Diano et al., 2003;
Kohno et al., 2003, 2008; Yamanaka et al., 2003; Murphy et al.,
2009b; Sheng et al., 2014). A role for ARC NPY/AgRP-GI neu-
rons in defending the brains energy supply during starvation
stands out in particular. Fasting increases NPY gene expres-
sion as well as cfos expression and action potential frequency
in ARC NPY/AgRP-GI neurons (Mizuno et al., 1999; Takahashi
and Cone, 2005; Becskei et al., 2009; Murphy et al., 2009b).
Fasting also increases hypothalamic NPY release and the activa-
tion of NPY/AgRP-GI neurons in response to decreased glucose
(Murphy et al., 2009b). These data are consistent with the over-
all role of hypothalamic NPY/AgRP neurons to stimulate food
intake (Billington and Levine, 1992; White, 1993). NPY express-
ing neurons are found in several brain regions which regulate
energy homeostasis including the ARC and brainstem. However,
AgRP expression is restricted to the ARC where it is found
in 95% of the NPY neurons (Broberger et al., 1998). AgRP is
an endogenous inhibitor of the melanocortin receptor. Thus,
NPY/AgRP neurons oppose the effects of the anorexigenic POMC
neurons at their targets. These targets include the hypothala-
mic paraventricular nucleus; a key site for regulating metabolism
and food intake. The corticotrophin releasing hormone neu-
rons which drive the hypothalamic-pituitary-adrenal axis as well
as pre-autonomic neurons which activate the sympathetic ner-
vous system reside in the paraventricular nucleus (Steffens et al.,
1972, 1988; van Dijk et al., 1994; Ahima et al., 2000; Elmquist,
2001; Watts and Sanchez-Watts, 2002). In addition to opposing
POMC neurons, NPY/AgRP neurons regulate energy partitioning
and substrate utilization in a melanocortin-independent fashion
(Joly-Amado et al., 2012). Importantly, AgRP deficiency impairs
ketone body release from the liver during starvation (Warne et al.,
2013). AgRP also mediates the gluconeogenic effects of ghrelin
(Wang et al., 2014). Thus, increased AgRP release, especially in
response to low glucose during starvation, may play a role in
enhancing gluconeogenesis as well as triggering increased ketone
production to fuel the brain. Similarly, increased activation of
VMN nNOS-GI neurons during low glucose is consistent with
enhanced gluconeogenesis (Fioramonti et al., 2010a). Orexin is
associated with enhanced reward-based feeding behavior as well
as increased sympathetic activity. Increased activity in low glu-
cose, especially during fasting, is consistent with this line of
reasoning (Antunes et al., 2001; Harris et al., 2005; Kelley et al.,
2005; Zheng et al., 2007; Choi et al., 2010; Perello et al., 2010;
Sheng et al., 2014). Moreover, we have recently shown that low
glucose enhances excitatory glutamate neurotransmission onto
ventral tegmental area dopamine neurons in an orexin depen-
dent manner (Sheng et al., 2014). This observation strongly
supports a role for orexin-GI neurons in reinforcing feeding
behavior when glucose levels decline. Finally, since growth hor-
mone is also released during hypoglycemia, it makes sense that
growth hormone releasing hormone neurons are also GI neu-
rons (Stanley et al., 2013). Together these data are consistent
with an overall role for hypothalamic GI neurons in provid-
ing the brain with fuel during energy deficit. An important
caveat to the above discussion is that the neurocircuitry which
controls autonomic and neuroendocrine systems is extremely
complex and its activation should never be considered in “all
or none” terms. Rather, the above is a generalization in order
to propose a physiological role for glucose sensing neurons and
form a framework for designing experiments which test these
hypotheses.
LINK NEUROENDOCRINE SYSTEMSWITH GLUCOSE STATUS
Another putative function for hypothalamic glucose sensing neu-
rons is to prevent activation of neuroendocrine systems which
use rather than provide fuel during energy deficit or conversely
to allow energy to be diverted to these systems when it will not
threaten the brain. For example, this may explain why subpopu-
lations GnRH neurons are glucose sensing (Roland and Moenter,
2011). In contrast to the GI neurons described above, GnRH
neurons are excited by glucose. Thus, when glucose levels are
sufficient reproductive function is supported. Conversely, during
times when food is scarce and glucose levels are low, the glucose
sensing function of these neurons would contribute to inhibition
of the reproductive axis. Moreover, while melanocortin concen-
trating hormone neurons stimulate food intake, they are also
associated with anabolic processes (increased fat mass, reproduc-
tion) which could divert fuel away from the brain (Naufahu et al.,
2013). Thus, reduced activity of melanocortin concentration
hormone-GE neurons in low glucose is consistent with our overall
hypothesis. However, one must use caution when trying to apply
this reasoning to all GE or GI neurons because the relationship
between the direction of glucose sensing (i.e., excited or inhibited
by glucose) will depend on whether that particular glucose sens-
ing neuron is inhibitory or stimulatory to the system in question.
This is further evidenced by the observation that both GE and
GI neurons are often found in the same hypothalamic nuclei. As
mentioned above, the homeostatic mechanisms regulated by the
hypothalamus are diverse and extremely complex. Thus, extreme
caution is warranted when attempting to generalize the function
of hypothalamic GE and GI neurons. Moreover, it is important to
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realize that there will be numerous exceptions to any rule for these
systems.
WHAT ABOUT ENERGY SURPLUS?
The preceding discussion of hypothalamic glucose sensing neu-
rons has focused on their role in sensing energy deficit. The
main reasons for this bias are as follows. Although glucose
concentration-response curves have only been published for
VMH GE and GI neurons, these data suggest that glucose sens-
ing neurons are primarily responsive to decreases in glucose
below brain glucose concentrations associated with peripheral
euglycemia (Wang et al., 2004; Song and Routh, 2005; Kang et al.,
2006; Murphy et al., 2009b). In addition, their glucose sensitivity
is altered under conditions associated with a need to sense energy
deficit. That is, fasting reduces the inhibitory effect of glucose on
VMH GI neurons leading to increased activation in response to
smaller declines in glucose (Murphy et al., 2009b). Moreover, the
glucose sensitivity of both VMHGE and GI neurons shifts in par-
allel with the ability of the brain to sense and respond to insulin-
induced hypoglycemia (Song and Routh, 2005, 2006; Kang et al.,
2008; Diggs-Andrews et al., 2010; Fioramonti et al., 2010a,b,
2013). In contrast, there is less known about glucose sensing neu-
rons during hyperglycemia. We found that acute hyperglycemia
prevents VMH GI neurons from producing NO and depolarizing
in response to decreased glucose as a result of mTOR inhibition
of AMPK (Canabal et al., 2007a). Conversely, while inhibition of
VMHGE neurons from diabetic db/dbmice to a maximal glucose
decrease to 0.1mM was identical to that of non-diabetic controls,
the inhibition in response to a mid-range decrease (0.5mM) was
significantly enhanced in the diabetic mice (Cotero et al., 2009).
Spanswick and colleagues found no difference in glucose sensi-
tivity of VMH GE neurons in Zucker obese fa/fa rats compared
to lean Fa/Fa rats; however they only evaluated the response of
these neurons to a glucose decrease from 10 to 0mM (Spanswick
et al., 2000). Finally, 2 additional subtypes of ARC glucose sens-
ing neurons have been identified which respond to changes
in extracellular glucose above 5mM: the high-GE (HGE) and
high-GI (HGI) neurons (Fioramonti et al., 2004). As mentioned
above, brain glucose concentrations above 5mM have never been
observed. However, since the permeability of the blood brain bar-
rier changes with nutrient status it is possible that these glucose
sensing neurons may play a role in glucose detection under some
situations (Langlet et al., 2013). Such a role is consistent with
data from Luc Penicaud’s group showing that centrally restricted
glucose infusion via the carotid artery increased cfos expres-
sion in ARC and paraventricular nucleus neurons and astrocytes
which was associated with transient peripheral insulin secretion
(Guillod-Maximin et al., 2004). Based on the above findings,
it is tempting to speculate that the brain has a mechanism for
sensing hyperglycemia and modulating peripheral metabolism
in response. Furthermore, disrupted glucose sensing in diabetes
suggests that glucose sensing neurons may play a role in the
pathology of metabolic syndrome. In fact, an enhanced response
to glucose deficit during conditions of energy sufficiency or even
surplus (e.g., obesity/diabetes) could potentially lead to similar
compensatory mechanisms as in response to fasting or starvation.
Such changes could further enhance the obese state. However, due
to a lack of data such comments are purely speculative at this
time.
INTERACTIONWITH NON-HYPOTHALAMIC GLUCOSE
SENSORS
While the focus of this review is on hypothalamic glucose sensing
neurons, glucose sensing neurons are also found in many other
brain regions including the amygdala (Nakano and Oomura,
1986; Zhou et al., 2010), nucleus solitarius (Adachi et al., 1984)
and midbrain (Levin, 2000). Moreover, although glucose sens-
ing neurons per se have not been identified in the hindbrain,
neurons within this region clearly respond to glucoprivation
(Ritter et al., 1998, 2011; Routh et al., 2013). There are also
glucose sensors located in numerous peripheral sites including
the carotid bodies (Alvarez-Buylla and de Alvarez-Buylla, 1998;
Pardal and Lopez-Barneo, 2002; Lopez-Barneo, 2003), portal-
mesenteric vein (Donovan et al., 1994; Hevener et al., 1997;
Matveyenko and Donovan, 2006) and intestine (Sayegh et al.,
2004; Raybould, 2007; Ackroff et al., 2010). The regulation of glu-
cose homeostasis clearly involves integration of information from
multiple glucose sensing regions. For example, the hypothalamus,
hindbrain and portal-mesenteric vein glucose sensors are all crit-
ical for hypoglycemia detection and full initiation of the CRR
(Routh et al., 2013). Unraveling the physiological function of the
many glucose sensing brain regions and how they work together
is an evolving field which requires a great deal more work in order
to understand.
CONCLUSION: THE SELFISH BRAIN
In conclusion, the hypothalamus is the primary site of integration
for the neuroendocrine and autonomic responses which main-
tain energy and glucose homeostasis. Within the hypothalamus
sensory neurons respond to circulating nutrients and hormones
in order to inform the brain regarding peripheral metabolic
homeostasis. The presence of glucose sensing neurons within the
hypothalamus suggests a sensitive mechanism for maintaining a
constant glucose supply to the brain. There is evidence for a role of
glucose sensing neurons in hypoglycemia detection and initiation
of the CRR during modern iatrogenic hypoglycemia (Song and
Routh, 2006; Fioramonti et al., 2010a,b, 2013; Routh et al., 2013).
However, it is likely that glucose sensing neurons actually evolved
to protect the brain during intermittent starvation. For example,
fasting increases the activation of NPY/AgRP-GI and orexin-GI
neurons by decreased glucose (Murphy et al., 2009b). This could
provide glucose for the brain in several ways; including increased
food intake, initiating gluconeogenesis and mediating the shift
to ketogenesis should the threat be sufficient (Beck, 2000; Joly-
Amado et al., 2012; Warne et al., 2013; Sheng et al., 2014; Wang
et al., 2014). Should similar fasting-induced changes in the glu-
cose sensitivity of VMN nNOS- and growth hormone releasing
hormone-GI neurons occur, this could also contribute to ensur-
ing adequate fuel to the brain (Cai et al., 1999; Fioramonti et al.,
2010a; Stanley et al., 2013). In contrast, other subtypes of glu-
cose sensing neurons may divert energy away from competing
systems (e.g., reproductive axis Roland and Moenter, 2011) when
glucose levels are low. On the other hand, when the energy needs
of the brain are met, the response of glucose sensing neurons to
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low glucose may be “deactivated” as seen for the effect of leptin
and insulin on VMH GI and GE neurons, respectively (Cotero
and Routh, 2009; Murphy et al., 2009b). Thus, we hypothesize
that during energy deficit glucose sensing neurons are enlisted in
order to enable the brain to prioritize its own energy needs at the
expense of other energy requiring systems. However, clearly much
work remains to determine the viability of our hypothesis.
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